4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-065820
Director sold 755 shares at $40.11 ($30,283)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salter Malcolm Director | 2021-11-19 | Sale | −755 | $40.11 | $30,283 | 11,707 | D |
| Open-market sales · 755 sh · avg $40.11 · $30,283 | |||||||
Loading xslF345X03/doc4.xml…